| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Erdafitnib | N-(2-((3, 5-dimethoxyphenyl)(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)amino)ethyl)-N-isopropylformamide | VE0015718 | View |
Erdafitnib Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Erdafitnib | N-(2-((3, 5-dimethoxyphenyl)(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)amino)ethyl)-N-isopropylformamide | VE0015718 | View |
[rfq_list]
| Catalogue No. | VE0015718 |
| CAS No. | N/A |
| Molecular Formula | C26H30N6O3 |
| Molecular Weight | 474.6 g/mol |
| Parent drug | Erdafitnib |
| IUPAC Name | N-(2-((3, 5-dimethoxyphenyl)(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)amino)ethyl)-N-isopropylformamide |
| Synonyms | N/A |
| Smiles | – |
| References | – |
| Status | In-stock |
| ListName | N-(2-((3, 5-dimethoxyphenyl)(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)amino)ethyl)-N-isopropylformamide |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
